Cephalon Deals Went Beyond Provigil: Direct Buyers

By Ben James

Law360, New York (January 06, 2010, 7:36 PM ET) -- Direct purchaser plaintiffs suing Cephalon Inc. and several generic-drug makers for striking allegedly illegal deals to keep a copycat version of narcolepsy drug Provigil off the market have filed an amended complaint that they say identifies more anti-competitive and illegal aspects of the settlements at issue.

The plaintiffs — a group that includes King Drug Company of Florence Inc., Meijer Inc. and Rochester Drug Co-Operative Inc. — filed their second amended consolidated class action complaint Wednesday after getting a green light from Judge Mitchell Goldberg of...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles